Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 4/11/14 → 11/28/18 |
Financiación
- Baxter Healthcare Co: 26.363,00 US$
BAX855 Extension-A Phase 3B Continuation Study of the Safety and Efficacy of PEGylated Recombinant Factor VII in Prophylaxis of Bleeding in Previously Treated Patients with Severe Hemophilia A
- Radulescu, Vlad (PI)